Woodline Partners’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.53M | Hold |
|
|||||
|
2025
Q1 | $5.67M | Hold |
|
|||||
|
2024
Q4 | $6.89M | Buy |
|
|||||
|
2024
Q3 | $2.1M | Buy |
|
|||||
|
2024
Q2 | $1.78M | Buy |
|
|||||
|
2024
Q1 | $1.34M | Sell |
|
|||||
|
2023
Q4 | $1.24M | Buy |
|
|||||
|
2023
Q3 | $827K | Buy |
|
|||||
|
2023
Q2 | $708K | Hold |
|
|||||
|
2023
Q1 | $1.22M | Hold |
|
|||||
|
2022
Q4 | $1.18M | Hold |
|
|||||
|
2022
Q3 | $1.43M | Hold |
|
|||||
|
2022
Q2 | $1.26M | Sell |
|
|||||
|
2022
Q1 | $2.65M | Sell |
|
|||||
|
2021
Q4 | $3.45M | Hold |
|
|||||
|
2021
Q3 | $4.83M | Sell |
|
|||||
|
2021
Q2 | $6.78M | Sell |
|
|||||
|
2021
Q1 | $9.53M | Sell |
|
|||||
|
2020
Q4 | $13.7M | Buy |
|